Hospital Del Mar
Hospital Del Mar is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
CHOP PLUS MOSUNETUZUMAB AS FIRST LINE IN PATIENTS WITH RICHTER´S SYNDROME: A PHASE II STUDY OF THE SPANISH GROUP OF CLL (GELLC-9-RICHTER)
Sponsor Not reported
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, open-label, randomized, 2-arm, phase II study to evaluate the efficacy and safety of cetuximab plus irinotecan rechallenge compared with investigator's choice of therapy in the third-line setting in ctDNA genomically selected patients with metastatic colorectal cancer (CITRIC Study)
Sponsor Associacio Per A La Recerca Oncologica
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase III randomized sequential open-label study to evaluate the efficacy of FOLFOX + panitumumab followed by FOLFIRI + bevacizumab (Sequence 1) versus FOLFOX + bevacizumab followed by FOLFIRI + panitumumab (Sequence 2) in untreated patients with wild-type RAS metastatic, primary left-sided, unresectable colorectal cancer: The CR-SEQUENCE
Sponsor Asociacion Grupo Tratamiento De Tumores Digestivos
- Start (EU)
- Latest update
- Estimated end
- Not reported
Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study.
Sponsor Hospital Universitari De Girona Doctor Josep Trueta
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Hospital Del Mar?
The 2026-10-09 snapshot links Hospital Del Mar to 4 distinct CTIS trials. Recorded services include Laboratory services, Liquid chromatography mass spectrometry (LC-MS/MS). These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Hospital Del Mar?
The most frequently recorded therapeutic areas are Haematological Malignancies. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Hospital Del Mar conducted?
The linked trials record locations in 2 countries, including Spain, Portugal. These are trial locations, not confirmed office locations or countries where Hospital Del Mar delivered services.
What can this page tell me about Hospital Del Mar's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Hospital Del Mar. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Hospital Del Mar